Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose quadrivalent influenza vaccine in elderly Taiwanese adults
NCT04537234Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2020
- Primary completion
- Feb 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of trivalent inactivated influenza vaccine high-dose in influenza, sponsored by Sanofi. Started Nov 2020; status: completed.
02
Drugs
trivalent inactivated influenza vaccine high-dose
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04537234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04537234.